Ethos Financial Group’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History
Bought
Maintained
Sold
Other funds holding BTAL
FDCDDQ
CCA
AWM
KF
OIA
CGA
Ethos Financial Group's BTAL Position: Q2 2026 in Review
Ethos Financial Group reduced its AGF US Market Neutral Anti-Beta Fund (BTAL) stake by 0.36% in Q2 2026, selling an estimated $1.17K and leaving 26,455 shares worth $336K. The position accounts for 0.02% of the portfolio, ranked #452.
Ethos Financial Group first reported a position in BTAL in Q4 2022 and has held it in 15 quarters since. The position peaked at $13M in Q4 2022. 93 funds tracked by Wall St. Rank hold BTAL as of Q2 2026.
- Ethos Financial Group held 26,455 shares of AGF US Market Neutral Anti-Beta Fund worth $336K as of Q2 2026.
- Ethos Financial Group sold 96 AGF US Market Neutral Anti-Beta Fund shares in Q2 2026, an estimated $1.17K.
- AGF US Market Neutral Anti-Beta Fund made up 0.02% of Ethos Financial Group's portfolio in Q2 2026, its #452 holding.
- Ethos Financial Group first reported a position in AGF US Market Neutral Anti-Beta Fund in Q4 2022 and has held it in 15 quarters since.
- Ethos Financial Group's AGF US Market Neutral Anti-Beta Fund position peaked at $13M in Q4 2022.
- 93 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q2 2026.
Based on Ethos Financial Group's 13F filing for Q2 2026, filed 7 Aug 2026.